Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo
Abstract Background Cisplatin-based chemotherapy is the first-line treatment for ovarian cancer. However, acquired resistance to cisplatin treatment often occurs in epithelial ovarian cancer, and effective and practical methods for overcoming this obstacle are urgently needed. The study aimed to dem...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , |
---|---|
Format: | Livre |
Publié: |
BMC,
2019-11-01T00:00:00Z.
|
Sujets: | |
Accès en ligne: | Connect to this object online. |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Internet
Connect to this object online.3rd Floor Main Library
Cote: |
A1234.567 |
---|---|
Exemplaire 1 | Disponible |